Steven J. Kussick, M.D., Ph.D., is Associate Medical Director, Director of Hematopathology, and Director of Flow Cytometry at PhenoPath Laboratories in Seattle. He has extensive experience in the use of morphologic, immunophenotypic, and molecular methods in the diagnosis of hematolymphoid neoplasms.
Dr. Kussick received his undergraduate education at Brown University, then spent two years studying in London on a Marshall Scholarship. He then did M.D. and Ph.D. studies in the Medical Scientist Training Program at the University of Washington, followed by Anatomic Pathology Residency and Hematopathology Fellowship at the University of Washington. He is board-certified in Anatomic Pathology and Hematopathology. Prior to joining PhenoPath, Dr. Kussick was Associate Director of Hematopathology in the Department of Laboratory Medicine at the University of Washington, and remains an affiliate faculty member there. At PhenoPath, Dr. Kussick established the 9-color clinical flow cytometry laboratory in 2005, and transitioned the methodology to 10-color analysis in 2010. He has also validated numerous new PhenoPath IHC assays related to hematopathology. In addition to 15 years of attending experience in diagnostic hematopathology, Dr. Kussick has a broad research background, with over 30 peer-reviewed research publications in areas including flow cytometry, hematopathology, basic cancer biology and chronic disease epidemiology. He currently serves as the central pathologist for a number of international clinical trials related to lymphoma.